https://www.podbean.com/media/share/pb-a4heh-1900908
In this episode of the Women’s Football Hub Podcast, host Carolyn Kent is joined by Dr Jessica Beal Stahl and sports pharmacist Emily Shears for a critical conversation about GLP-1 receptor agonists – better known as Ozempic, Wegovy, and Mounjaro.
We unpack:
-
How these drugs work in the body
-
Why they were developed for diabetes and are now used more broadly (including PCOS, weight loss)
-
Risks and side effects (appetite suppression, GI distress, nutrient depletion, ‘Ozempic teeth’, hormonal impacts)
-
Black market concerns and safety issues
-
Implications for female athletes (RED-S, sarcopenia, performance monitoring)
-
Ethical and regulatory questions around sport
This episode is essential for athletes, coaches, clinicians and anyone supporting female players.
🛒 Support the Hub by visiting www.womensfootballhub.com
⚠️ Disclaimer: This podcast is for informational purposes only and is not medical advice. Please consult a healthcare professional for personal guidance.
#WomensFootballHub #FemaleAthleteHealth #GLP1 #Ozempic #Wegovy #Mounjaro #SportsPharmacy

Leave a comment